Ohio Public Employees Retirement System (OPERS)’s Allogene Therapeutics ALLO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$554K	Buy	266,417 +88,542	+50%	+$194K	﹤0.01%	1472
2026 Q1	$434K	Buy	+177,875	New	+$357K	﹤0.01%	1516
2024 Q3	–	Sell	-57,300	Closed	-$134K	–	2203
2024 Q2	$134K	Buy	+57,300	New	+$169K	﹤0.01%	1402
2022 Q4	–	Sell	-51,979	Closed	-$561K	–	1966
2022 Q3	$561K	Buy	+51,979	New	+$706K	﹤0.01%	1316

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s ALLO Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Allogene Therapeutics (ALLO) stake by 50% in Q2 2026, buying an estimated $194K and bringing the position to 266,417 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.

Ohio Public Employees Retirement System (OPERS) first reported a position in ALLO in Q3 2022 and has held it in 4 quarters since. The position peaked at $561K in Q3 2022. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

Ohio Public Employees Retirement System (OPERS) held 266,417 shares of Allogene Therapeutics worth $554K as of Q2 2026.
Ohio Public Employees Retirement System (OPERS) bought 88,542 Allogene Therapeutics shares in Q2 2026, an estimated $194K.
Allogene Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1472 holding.
Ohio Public Employees Retirement System (OPERS) first reported a position in Allogene Therapeutics in Q3 2022 and has held it in 4 quarters since.
Ohio Public Employees Retirement System (OPERS)'s Allogene Therapeutics position peaked at $561K in Q3 2022.
209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.